Protection of Mice against Lethal Coxsackievirus B3 Infection by Using DNA Immunization
AUTOR(ES)
Henke, Andreas
FONTE
American Society for Microbiology
RESUMO
Vaccination with DNA and recombinant vaccinia viruses (rec.VV) has been studied with the coxsackievirus B3 (CVB3) model system. Plasmids encoding all structural proteins of CVB3, when injected intramuscularly, induced only low levels of virus-specific antibodies. However, DNA vaccination with the major structural protein VP1 protected 72.2% of mice from lethal challenge, whereas VP1 expressed by rec.VV was much less efficient.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=110201Documentos Relacionados
- Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis
- DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection.
- Modification of Severe Coxsackievirus B3 Infection in Marasmic Mice by Transfer of Immune Lymphoid Cells
- Temperature-Sensitive Mutant of Coxsackievirus B3 Establishes Resistance in Neonatal Mice That Protects Them During Adolescence Against Coxsackievirus B3-Induced Myocarditis
- Intranasal Immunization of Mice with Group B Streptococcal Protein Rib and Cholera Toxin B Subunit Confers Protection against Lethal Infection
